The InSiDe instrument has now been employed in clinical feasibility studies in France and the Netherlands for assessing ...

Incorporating chewing into the daily lives of our dogs may be one simple yet important way to ensure they are living happy ...

Refusing to know better by not holding an independent COVID inquiry (both federally and provincially/territorially) commits ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy and as the backbone for novel ...

Allergy season is getting longer thanks to climate change. Learn how to cope and how to tell whether you have allergies or a ...

Visionary entrepreneurs are the driving force behind innovation and industry transformation. 2025’s Top 10 Visionary ...

The Cambridge-based biotech's experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, ...

Wave Life Sciences (WVE) stock rises on plans to file for FDA accelerated approval of WVE-N531 in 2026, targeting Duchenne muscular dystrophy. Read more here.

Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

A new diagnostic tool at OU Health in Oklahoma City is helping doctors uncover and treat coronary microvascular disease.

Studies show that excessive sitting takes a toll on your body, especially your heart. While you can't change genetics, you can change some lifestyle factors.